换一批
换一批
作者：
Alexander M,Frankell [1]
;
Michelle,Dietzen [2]
;
Maise,Al Bakir [1]
;
Emilia L,Lim [1]
;
Takahiro,Karasaki [3]
;
Sophia,Ward [4]
;
Selvaraju,Veeriah [5]
;
Emma,Colliver [6]
;
Ariana,Huebner [2]
;
Abigail,Bunkum [7]
;
Mark S,Hill [6]
;
Kristiana,Grigoriadis [2]
;
David A,Moore [8]
;
James R M,Black [9]
;
Wing Kin,Liu [10]
;
Kerstin,Thol [9]
;
Oriol,Pich [6]
;
Thomas B K,Watkins [6]
;
Cristina,Naceur-Lombardelli [5]
;
Daniel E,Cook [6]
;
Roberto,Salgado [11]
;
Gareth A,Wilson [6]
;
Chris,Bailey [6]
;
Mihaela,Angelova [6]
;
Robert,Bentham [9]
;
Carlos,Martínez-Ruiz [9]
;
Christopher,Abbosh [5]
;
Andrew G,Nicholson [12]
;
John,Le Quesne [13]
;
Dhruva,Biswas [14]
;
Rachel,Rosenthal [6]
;
Clare,Puttick [2]
;
Sonya,Hessey [7]
;
Claudia,Lee [15]
;
Paulina,Prymas [5]
;
Antonia,Toncheva [5]
;
Jon,Smith [16]
;
Wei,Xing [16]
;
Jerome,Nicod [17]
;
Gillian,Price [18]
;
Keith M,Kerr [19]
;
Babu,Naidu [20]
;
Gary,Middleton [21]
;
Kevin G,Blyth [22]
;
Dean A,Fennell [23]
;
Martin D,Forster [24]
;
Siow Ming,Lee [24]
;
Mary,Falzon [25]
;
Madeleine,Hewish [26]
;
Michael J,Shackcloth [27]
;
Eric,Lim [28]
;
Sarah,Benafif [29]
;
Peter,Russell [30]
;
Ekaterini,Boleti [31]
;
Matthew G,Krebs [32]
;
Jason F,Lester [33]
;
Dionysis,Papadatos-Pastos [29]
;
Tanya,Ahmad [29]
;
Ricky M,Thakrar [34]
;
David,Lawrence [35]
;
Neal,Navani [34]
;
Sam M,Janes [36]
;
Caroline,Dive [37]
;
Fiona H,Blackhall [32]
;
Yvonne,Summers [32]
;
Judith,Cave [38]
;
Teresa,Marafioti [25]
;
Javier,Herrero [39]
;
Sergio A,Quezada [40]
;
Karl S,Peggs [41]
;
Roland F,Schwarz [42]
;
Peter,Van Loo [43]
;
Daniël M,Miedema [44]
;
Nicolai J,Birkbak [45]
;
Crispin T,Hiley [1]
;
Allan,Hackshaw [46]
;
Simone,Zaccaria [47]
;
TRACERx Consortium [48]
;
Mariam,Jamal-Hanjani [49]
;
Nicholas,McGranahan [50]
;
Charles,Swanton
作者单位：
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.;Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
[1]
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.;Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.;Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
[2]
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.;Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.;Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.
[3]
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.;Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.;Advanced Sequencing Facility, The Francis Crick Institute, London, UK.
[4]
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
[5]
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
[6]
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.;Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.;Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK.
[7]
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.;Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.;Department of Cellular Pathology, University College London Hospitals, London, UK.
[8]
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.;Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
[9]
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.;Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.
[10]
Department of Pathology, ZAS Hospitals, Antwerp, Belgium.;Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
[11]
Department of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.;National Heart and Lung Institute, Imperial College London, London, UK.
[12]
Cancer Research UK Beatson Institute, Glasgow, UK.;School of Cancer Sciences, University of Glasgow, Glasgow, UK.;Pathology Department, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK.
[13]
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.;Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.;Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.
[14]
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.;Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.;Division of Medicine, University College London, London, UK.
[15]
Scientific Computing, The Francis Crick Institute, London, UK.
[16]
Advanced Sequencing Facility, The Francis Crick Institute, London, UK.
[17]
Department of Medical Oncology, Aberdeen Royal Infirmary NHS Grampian, Aberdeen, UK.;University of Aberdeen, Aberdeen, UK.
[18]
University of Aberdeen, Aberdeen, UK.;Department of Pathology, Aberdeen Royal Infirmary NHS Grampian, Aberdeen, UK.
[19]
Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.;University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.
[20]
University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.;Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
[21]
Cancer Research UK Beatson Institute, Glasgow, UK.;School of Cancer Sciences, University of Glasgow, Glasgow, UK.;Queen Elizabeth University Hospital, Glasgow, UK.
[22]
University of Leicester, Leicester, UK.;University Hospitals of Leicester NHS Trust, Leicester, UK.
[23]
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.;Department of Oncology, University College London Hospitals, London, UK.
[24]
Department of Cellular Pathology, University College London Hospitals, London, UK.
[25]
Royal Surrey Hospital, Royal Surrey Hospitals NHS Foundation Trust, Guilford, UK.;University of Surrey, Guilford, UK.
[26]
Liverpool Heart and Chest Hospital, Liverpool, UK.
[27]
Academic Division of Thoracic Surgery, Imperial College London, London, UK.;Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
[28]
Department of Oncology, University College London Hospitals, London, UK.
[29]
Princess Alexandra Hospital, The Princess Alexandra Hospital NHS Trust, Harlow, UK.
[30]
Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.
[31]
Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK.
[32]
Singleton Hospital, Swansea Bay University Health Board, Swansea, UK.
[33]
Department of Thoracic Medicine, University College London Hospitals, London, UK.;Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
[34]
Department of Thoracic Surgery, University College London Hospital NHS Trust, London, UK.
[35]
Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
[36]
Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.;Cancer Research UK Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK.
[37]
Department of Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
[38]
Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.
[39]
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.;Immune Regulation and Tumour Immunotherapy Group, Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
[40]
Department of Haematology, University College London Hospitals, London, UK.;Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
[41]
Institute for Computational Cancer Biology, Center for Integrated Oncology (CIO), Cancer Research Center Cologne Essen (CCCE), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.;Berlin Institute for the Foundations of Learning and Data (BIFOLD), Berlin, Germany.
[42]
Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.;Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.;Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.
[43]
LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.;Oncode Institute, Amsterdam, The Netherlands.
[44]
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.;Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.;Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.;Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.;Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark.
[45]
Cancer Research UK and UCL Cancer Trials Centre, London, UK.
[46]
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.;Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK.
[47]
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.;Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.;Department of Oncology, University College London Hospitals, London, UK. m.jamal-hanjani@ucl.ac.uk.
[48]
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.;Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.
[49]
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.;Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.;Department of Oncology, University College London Hospitals, London, UK. charles.swanton@crick.ac.uk.
[50]
DOI
10.1038/s41586-024-07738-w
PMID
38965439
发布时间
2024-07-27
- 浏览0
Nature
Nature
E15页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
